Curis
CRIS
#10248
Rank
NZ$24.02 M
Marketcap
NZ$1.86
Share price
-6.96%
Change (1 day)
-65.90%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.37. In 2024 the company made an earnings per share (EPS) of NZ-$12.21 an increase over its 2023 EPS that were of NZ-$15.68.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-47.72%
2024NZ-$12.21-22.15%
2023NZ-$15.68-26.17%
2022NZ-$21.2422.3%
2021NZ-$17.37-25.37%
2020NZ-$23.27-30.93%
2019NZ-$33.69-2.02%
2018NZ-$34.39
2016NZ-$78.15-10%
2015NZ-$86.84138.1%
2014NZ-$36.4740%
2013NZ-$26.05-25%
2012NZ-$34.7366.67%
2011NZ-$20.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
NZ$4.13-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.45-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.63-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.87-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.99-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.16-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.52 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA